A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Public ClinicalTrials.gov record NCT02660944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Double-blind, Placebo-Controlled Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the impact of 13 bi-weekly intravenous infusions of RSLV-132 on the cutaneous manifestations in subjects with systemic lupus erythematosus.
Study identification
- NCT ID
- NCT02660944
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2016
- Primary completion
- May 27, 2020
- Completion
- Aug 9, 2020
- Last update posted
- Mar 9, 2021
2016 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TriWest Research Associates | El Cajon | California | 92020 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| Valerius Research Center | Los Alamitos | California | 90720 | — |
| Wallace Rheumatic Study Center | Los Angeles | California | 90048 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | — |
| Center for Rheumatology, Immunology and Arthritis | Fort Lauderdale | Florida | 33309 | — |
| Alper Research | Naples | Florida | 34102 | — |
| Northwell Health/ Division of Rheumatology | Great Neck | New York | 11042 | — |
| Feinstein Institute for Medical Research | Manhasset | New York | 11030 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28210 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Temple University | Philadelphia | Pennsylvania | 19140 | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| Accurate Clinical Research | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02660944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02660944 live on ClinicalTrials.gov.